CJC-1295 (No DAC)/Ipamorelin Blend 5/5mg

Important dilution note: Cloudiness after dilution is most commonly associated with non-pharmaceutical-grade dilution solution. Cloudy product concerns are not eligible for refund unless Pfizer pharmaceutical-grade dilution solution was used.

Vial Size: 3ml

Form: White Lyophilized Powder

Blend Composition: 5mg CJC-1295 (No DAC) + 5mg Ipamorelin per vial

Molecular Formula: N/A — blend; see component data below

Molecular Weight: N/A — blend; see component data below

CJC-1295 (No DAC) — CAS Number: 863288-34-0
CJC-1295 (No DAC) — Chemical Name: Modified GRF(1-29); [Ala², Ala⁸, Gln¹⁶, Leu¹⁸, Gln²⁷, Tyr²⁹]-GHRH(1-29)-NH₂
CJC-1295 (No DAC) — Synonyms: Mod GRF 1-29; Modified Growth Hormone-Releasing Factor (1-29)-amide
CJC-1295 (No DAC) — Molecular Weight: 3,367.9 g/mol
CJC-1295 (No DAC) — Sequence: 29-amino acid modified human GHRH(1-29) analog with substitutions for improved metabolic stability; C-terminal amide
CJC-1295 (No DAC) — Receptor Activity: Selective GHRH receptor (GHRH-R) agonist; studied for pulsatile GH release via Gs-coupled cAMP/PKA signaling without DAC-mediated albumin binding

Ipamorelin — CAS Number: 170851-70-4
Ipamorelin — Chemical Name: Ipamorelin
Ipamorelin — Synonyms: NNC 26-0161; GHSR-1a pentapeptide agonist
Ipamorelin — Molecular Weight: 711.9 g/mol
Ipamorelin — Sequence: Aib-His-D-2Nal-D-Phe-Lys-NH₂; synthetic pentapeptide GHSR-1a agonist
Ipamorelin — Receptor Activity: Selective GHSR-1a agonist; studied for GH pulse stimulation without concurrent elevation of cortisol, ACTH, or prolactin

Purity: ≥98% each component (HPLC) — see batch COA

Form: Lyophilized white to off-white powder

Storage Conditions: Store at −20°C, desiccated, protected from light. Stable 24 months lyophilized.

Solubility: Soluble in sterile water or 0.5% acetic acid at ≥1 mg/mL

Certificate of Analysis: Available for all batches.

For research and laboratory use only. Not for human or animal consumption. This product has not been evaluated by the FDA and is not intended to diagnose, treat, cure, or prevent any disease or condition. For use by qualified research professionals only.

Important dilution note: Cloudiness after dilution is most commonly associated with non-pharmaceutical-grade dilution solution. Cloudy product concerns are not eligible for refund unless Pfizer pharmaceutical-grade dilution solution was used.

Vial Size: 3ml

Form: White Lyophilized Powder

Blend Composition: 5mg CJC-1295 (No DAC) + 5mg Ipamorelin per vial

Molecular Formula: N/A — blend; see component data below

Molecular Weight: N/A — blend; see component data below

CJC-1295 (No DAC) — CAS Number: 863288-34-0
CJC-1295 (No DAC) — Chemical Name: Modified GRF(1-29); [Ala², Ala⁸, Gln¹⁶, Leu¹⁸, Gln²⁷, Tyr²⁹]-GHRH(1-29)-NH₂
CJC-1295 (No DAC) — Synonyms: Mod GRF 1-29; Modified Growth Hormone-Releasing Factor (1-29)-amide
CJC-1295 (No DAC) — Molecular Weight: 3,367.9 g/mol
CJC-1295 (No DAC) — Sequence: 29-amino acid modified human GHRH(1-29) analog with substitutions for improved metabolic stability; C-terminal amide
CJC-1295 (No DAC) — Receptor Activity: Selective GHRH receptor (GHRH-R) agonist; studied for pulsatile GH release via Gs-coupled cAMP/PKA signaling without DAC-mediated albumin binding

Ipamorelin — CAS Number: 170851-70-4
Ipamorelin — Chemical Name: Ipamorelin
Ipamorelin — Synonyms: NNC 26-0161; GHSR-1a pentapeptide agonist
Ipamorelin — Molecular Weight: 711.9 g/mol
Ipamorelin — Sequence: Aib-His-D-2Nal-D-Phe-Lys-NH₂; synthetic pentapeptide GHSR-1a agonist
Ipamorelin — Receptor Activity: Selective GHSR-1a agonist; studied for GH pulse stimulation without concurrent elevation of cortisol, ACTH, or prolactin

Purity: ≥98% each component (HPLC) — see batch COA

Form: Lyophilized white to off-white powder

Storage Conditions: Store at −20°C, desiccated, protected from light. Stable 24 months lyophilized.

Solubility: Soluble in sterile water or 0.5% acetic acid at ≥1 mg/mL

Certificate of Analysis: Available for all batches.

For research and laboratory use only. Not for human or animal consumption. This product has not been evaluated by the FDA and is not intended to diagnose, treat, cure, or prevent any disease or condition. For use by qualified research professionals only.